Cboe UK EUR

Pharma Mar, S.A. (PHME.XC)

Compare
68.82 0.00 (0.00%)
At close: October 16 at 3:10:28 PM GMT+1
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,649.00
-13,446.00
38,321.00
25,677.00
278,942.00
Investing Cash Flow
-17,701.00
-43,048.00
10,878.00
18,472.00
-119,009.00
Financing Cash Flow
-15,883.00
-32,137.00
-13,370.00
-27,415.00
-73,820.00
End Cash Position
38,040.00
60,024.00
149,813.00
113,348.00
96,210.00
Capital Expenditure
-19,316.00
-15,956.00
-8,852.00
-7,803.00
-3,002.00
Issuance of Capital Stock
2,646.00
18,606.00
57,227.00
33,554.00
30,366.00
Issuance of Debt
16,854.00
6,391.00
1,543.00
5,832.00
834.00
Repayment of Debt
-7,785.00
-7,544.00
-10,201.00
-15,270.00
-32,373.00
Repurchase of Capital Stock
-16,178.00
-37,901.00
-50,178.00
-40,659.00
-63,828.00
Free Cash Flow
-17,667.00
-29,402.00
29,469.00
17,874.00
275,940.00
12/31/2020 - 11/3/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade